DD275865A5 - Verfahren zur herstellung neuer cysteinderivate - Google Patents

Verfahren zur herstellung neuer cysteinderivate Download PDF

Info

Publication number
DD275865A5
DD275865A5 DD88321910A DD32191088A DD275865A5 DD 275865 A5 DD275865 A5 DD 275865A5 DD 88321910 A DD88321910 A DD 88321910A DD 32191088 A DD32191088 A DD 32191088A DD 275865 A5 DD275865 A5 DD 275865A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
optical isomer
cysteine
cooh
general formula
Prior art date
Application number
DD88321910A
Other languages
German (de)
English (en)
Inventor
Anders R Hallberg
Per A S Tunek
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD275865A5 publication Critical patent/DD275865A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DD88321910A 1987-11-19 1988-11-17 Verfahren zur herstellung neuer cysteinderivate DD275865A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704542A SE8704542D0 (sv) 1987-11-19 1987-11-19 New derivatives of cysteine

Publications (1)

Publication Number Publication Date
DD275865A5 true DD275865A5 (de) 1990-02-07

Family

ID=20370284

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88321910A DD275865A5 (de) 1987-11-19 1988-11-17 Verfahren zur herstellung neuer cysteinderivate

Country Status (27)

Country Link
EP (1) EP0317540B1 (fi)
JP (1) JPH02502189A (fi)
KR (1) KR890701553A (fi)
CN (1) CN1033802A (fi)
AR (1) AR245693A1 (fi)
AT (1) ATE79371T1 (fi)
AU (1) AU615244B2 (fi)
DD (1) DD275865A5 (fi)
DE (1) DE3873696T2 (fi)
DK (1) DK347789A (fi)
EG (1) EG19066A (fi)
ES (1) ES2051891T3 (fi)
FI (1) FI93442C (fi)
GR (1) GR3006115T3 (fi)
HU (1) HU203224B (fi)
IE (1) IE61181B1 (fi)
IL (1) IL88342A (fi)
IS (1) IS1544B (fi)
MY (1) MY106950A (fi)
NO (1) NO170413C (fi)
NZ (1) NZ226898A (fi)
PL (1) PL158450B1 (fi)
PT (1) PT89035B (fi)
SE (1) SE8704542D0 (fi)
WO (1) WO1989004825A1 (fi)
YU (1) YU46965B (fi)
ZA (1) ZA888509B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8901570D0 (sv) * 1989-05-02 1989-05-02 Draco Ab Organic salts of cysteine derivatives
WO1990014335A1 (en) * 1989-05-17 1990-11-29 Aktiebolaget Astra Process for the n-monoacylation of cysteine
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
CA2386985A1 (en) * 2000-08-11 2002-02-21 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
WO2023081784A1 (en) * 2021-11-03 2023-05-11 Lankenau Institute For Medical Research Compositions and methods for assessing and treating chemotherapy-induced peripheral neuropathy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB954268A (en) * 1962-02-26 1964-04-02 Mead Johnson & Co Decongestant compositions comprising n-acylated sulphydryl compounds
FR2470M (fr) * 1962-03-13 1964-04-20 Mead Johnson & Co Composition thérapeutique.
SE312633B (fi) * 1962-04-26 1969-07-21 Mead Johnson & Co
US3184505A (en) * 1962-06-18 1965-05-18 Mead Johnson & Co Process for the n-monoacylation of cysteine
US3242052A (en) * 1963-08-13 1966-03-22 Mead Johnson & Co Hair treatment with nu-acylcysteines
US4093740A (en) * 1973-02-16 1978-06-06 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessier Fodder for ruminants
JPS6011888B2 (ja) * 1978-10-11 1985-03-28 参天製薬株式会社 リウマチ疾患治療薬
IT1141654B (it) * 1980-01-31 1986-10-08 Alfa Farmaceutici Spa Nuovi derivati della cisteina ad attivita' antiinfiammatoria,analgesica,antipiretica e mucolitica

Also Published As

Publication number Publication date
YU46965B (sh) 1994-09-09
GR3006115T3 (fi) 1993-06-21
NO892787L (no) 1989-07-05
FI893478A (fi) 1989-07-18
EG19066A (en) 1994-09-29
EP0317540A1 (en) 1989-05-24
NZ226898A (en) 1991-01-29
DK347789D0 (da) 1989-07-13
IL88342A (en) 1993-07-08
KR890701553A (ko) 1989-12-20
FI93442B (fi) 1994-12-30
DE3873696D1 (de) 1992-09-17
PT89035A (pt) 1989-11-30
IE883418L (en) 1989-05-19
EP0317540B1 (en) 1992-08-12
YU207888A (en) 1990-02-28
CN1033802A (zh) 1989-07-12
HUT50759A (en) 1990-03-28
ZA888509B (en) 1989-07-26
ATE79371T1 (de) 1992-08-15
IE61181B1 (en) 1994-10-05
PL275851A1 (en) 1989-10-16
AU2729288A (en) 1989-06-14
PL158450B1 (pl) 1992-09-30
IS3413A7 (is) 1989-05-20
AR245693A1 (es) 1994-02-28
NO170413B (no) 1992-07-06
FI893478A0 (fi) 1989-07-18
NO892787D0 (no) 1989-07-05
IS1544B (is) 1994-06-08
JPH02502189A (ja) 1990-07-19
MY106950A (en) 1995-08-30
DK347789A (da) 1989-07-13
DE3873696T2 (de) 1993-01-28
PT89035B (pt) 1994-08-31
WO1989004825A1 (en) 1989-06-01
AU615244B2 (en) 1991-09-26
IL88342A0 (en) 1989-06-30
ES2051891T3 (es) 1994-07-01
NO170413C (no) 1992-10-14
HU203224B (en) 1991-06-28
FI93442C (fi) 1995-04-10
SE8704542D0 (sv) 1987-11-19

Similar Documents

Publication Publication Date Title
DE69733432T2 (de) N-(aryl/heteroaryl/alkylacetyl) amino saüre amide, pharmazeutische zusammensetzungen damit, und methodenzur inhibierung beta-amyloid peptid freisetzung oder synthese
DE69920496T2 (de) Piperidin- und pyrrolidin-derivate enthaltend ein stickstoffoxid donor zur behandlung von stress
DE2709820C2 (de) N-(Mercaptoacyl)-L oder DL-cysteine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende mucolytische Mittel
CH648549A5 (de) Amidderivate, verfahren zu deren herstellung und arzneimittel.
US5350768A (en) Derivatives of cysteine
DE2122273C3 (de) Substituierte Phenylessigsäureverbindungen, sie enthaltende entzündungshemmende, antipyretische und analgetische Mittel und Verfahren zu ihrer Herstellung
DE60013818T2 (de) Quaternäre ammoniumverbindungen, verfahren zu deren herstellung und deren pharmazeutische verwendung
DD275865A5 (de) Verfahren zur herstellung neuer cysteinderivate
CH650504A5 (de) Piperazinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE2903615A1 (de) Guajakacylester von mercaptopropionsaeurederivaten, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE2112057A1 (de) Neue Penicillinester
DE10008522A1 (de) Verwendung von 2-PHenylendiaminderivaten zur Behandlung von Infektionen
DE1926359A1 (de) oxylkansaeuren
DE3212027C2 (fi)
DE2937532A1 (de) Hydroxamsaeureverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
LU84062A1 (fr) Esters de mercaptoacyl-carnitines,procede pour leur preparation et leurs utilisations therapeutiques,notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
CH516593A (de) Verfahren zur Herstellung von neuen Estern von a-Aminobenzyl-penicillin
EP0035641B1 (de) Cysteinderivate, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
DE2311020A1 (de) Substituierte benzoesaeuren und arzneimittel
DE3153733C2 (de) Thiocarnitinhydrochloride
DE2932402A1 (de) Saeuresalze von benzol- und thiophen- carbothio-2-aminoalkylestern, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
DE3216986A1 (de) 2-methoxyphenyl ester von n-substituierten aminosaeuren, verfahren fuer deren herstellung und pharmazeutische diese enthaltenden verbindungen
DE3150084C2 (de) Verfahren zur Herstellung von Thiocarnitin-Halogeniden und diese enthaltende Arzneimittelzubereitungen
WO2001062745A1 (de) SUBSTITUIERTE 8,8a-DIHYDRO-3aH-INDENO[1,2-d]THIAZOLE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL
DE3102486A1 (de) Epoxybernsteinsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee